A new way to treat depression
Join over 100+ private clinics across the UK and Europe who are using tDCS technology to treat depression.
Increase choice, improve outcomes
Enhance results for patients
Combine Flow with therapy and/or antidepressants.
None of the side effects of drugs
Provide a new treatment option to patients who don’t want to be on antidepressants.
Alternative for treatment-resistant
Use Flow in cases where depression is hard to treat.
Clinic case study
Sarah is a psychiatrist working in private practice. Many of Sarah's patients suffer from depression.
Sarah recommends Flow when she wants to:
- Provide a patient with an alternative to antidepressants, or
- Enhance the results she is getting from therapy
When Sarah recommends Flow, the patient purchases a device from Flow's website.
Sarah can then oversee their treatment using Flow's Clinical Platform, which allows Sarah to remote monitor adherence and symptom change, and if necessary, adjust number of stimulation sessions available to the patient.
This gives Sarah new visibility of how the patient is progressing between in-person sessions.
By integrating Flow into her treatment program, Sarah has a new option for patients struggling with other treatment types.
Sarah's holistic offering of therapy, antidepressants and tDCS provides patients with greater choice and improved outcomes.
Leading academics and clinics support Flow
Flow’s exciting and encouraging data raise the prospect of a real advance in the treatment of depression…a helpful intervention for many people suffering from major depression.
Allan Young
Chair of Mood Disorders, King’s College London
Flow’s results show a clear separation of active and sham treatment in a large, multisite randomised controlled trial… a very promising development in mental health treatment.
Corey Keller
Assistant Professor of Psychiatry and Behavioural Sciences, Stanford University
Flow has gained popularity among our patients [in NHS pilots]. This positive reception speaks volumes about the effectiveness and patient satisfaction associated with Flow.
Dr Azhar Zafar
GPA Director of Research, NHS GP
If the patient has a poor response to antidepressants, I add Flow to the treatment plan. The modalities empower each other. We have grown our business with Flow.
Katrin Orav
Psychiatrist, Sensus
Home-based treatment that is safe and evidence-based. A major step forward for patients with depression.
Sophia Frangou, MD PhD
Professor of Psychiatry, Mount Sinai & Editor-in-Chief of European Psychiatry
With Flow’s brain stimulation headset our highly respected experts now have a new tool to treat depression.
Elena Touroni, PhD
Clinical Director, Chelsea Psychology Clinic
Flow has provided an additional means of treatment for our clinics and has increased our client base for both stand alone Flow users and as an add on to our TMS service.
BrainState TMS Clinic
